The Influence of Iatrogenic Chronotropic Incompetence on Exercise Tolerance in Pacemaker Patients With Chronic Heart Failure.
Phase of Trial: Phase II
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Ivabradine (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms TREPPE
- 30 Sep 2014 New trial record
- 29 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record..